Saud AlDubayan, MD

Saud is a board-certified clinical geneticist and computational biologist in the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute. Saud obtained his Medical Doctorate degree in 2009 and has done clinical training in adult medicine at the University of Toronto as well as clinical genetics and genomics at Harvard Medical School. Saud also did postdoctoral research training in computational biology at Dana-Farber Cancer Institute/Broad Institute, as well as translational genomics at Harvard Clinical and Translational Academy. In addition to clinically evaluating patients with inherited cancer-predisposition syndromes, Saud is also a dedicated scientist whose research interest has focused on exploring the utility of integrative DNA-repair centered analyses of paired germline and tumor genetic and transcriptomic data for informing clinical decision making. Saud’s current research work aims to explore novel inherited and somatic genomic predictors of cancer risk, cancer progression and chemoresistance in large cohorts of cancer patients.